Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 1.0 | 4.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.3 | 2.2 |
NAV | ₹25.66 | ₹100.44 |
Fund Started | 03 Sep 2015 | 25 Mar 1997 |
Fund Size | ₹46.71 Cr | ₹1072.74 Cr |
Exit Load | Exit load of 1% if redeemed within 1 year. | Exit load of 1%, if redeemed within 30 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 14.05% | 26.58% |
3 Year | 15.03% | 25.59% |
5 Year | 16.77% | 24.49% |
1 Year
3 Year
5 Year
Equity | 93.49% | 99.31% |
Cash | 0.71% | 0.69% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
ICICI Bank Ltd. | 7.69% |
HDFC Bank Ltd. | 7.00% |
Larsen & Toubro Ltd. | 6.71% |
State Bank of India | 5.92% |
Coal India Ltd. | 4.78% |
NTPC Ltd. | 4.08% |
Mahindra & Mahindra Ltd. | 3.51% |
National Aluminium Company Ltd. | 3.24% |
Spicejet Ltd. | 3.23% |
Bharti Airtel Ltd. | 3.11% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 7.21% |
Infosys Ltd. | 4.57% |
ICICI Bank Ltd. | 4.12% |
Dr. Reddy's Laboratories Ltd. | 3.14% |
State Bank of India | 2.74% |
NTPC Ltd. | 2.64% |
REC Ltd. | 2.49% |
Tech Mahindra Ltd. | 2.23% |
Amber Enterprises India Ltd. | 2.16% |
Suven Pharmaceuticals Ltd. | 2.07% |
Name | Anupam Tiwari | Satish Ramanathan |
Start Date | 03 Oct 2023 | 01 Oct 2024 |
Name
Start Date
Description | The Scheme seeks to generate returns through a combination of dividend income and capital appreciation by investing primarily in well-diversified portflio of value stocks. | The scheme aims to provide long term capital growth by investing primarily in a well-diversified portfolio of undervalued securities. |
Launch Date | 03 Sep 2015 | 25 Mar 1997 |
Description
Launch Date